Profile
Full Name
Biodesix, Inc.Ticker Symbol
BDSXExchange
NASDAQSector
HealthcareIndustry
Diagnostics & ResearchCountry
United StatesIPO
October 28, 2020Indexes
Not includedWebsite
http://www.biodesix.comEmployees
273Key Details
Price
$0.57(-5.45%)
Market cap
$83.50M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$71.32M(+45.30% YoY)
Annual EPS
-$0.33(+48.44% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Biodesix doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Sep 16, 24 Scotiabank
Sector OutperformJul 26, 24 Craig-Hallum
BuyMay 13, 24 TD Cowen
BuyMay 3, 24 Lake Street
BuyMar 4, 24 Canaccord Genuity
BuyDec 7, 23 Canaccord Genuity
BuyMay 12, 22 Morgan Stanley
Equal-WeightApr 20, 22 Cowen & Co.
OutperformNov 17, 21 Morgan Stanley
Equal-WeightMay 12, 21 Morgan Stanley
OverweightInstitutional Ownership
- What is the ticker symbol for Biodesix?
- Does Biodesix pay dividends?
- What sector is Biodesix in?
- What industry is Biodesix in?
- What country is Biodesix based in?
- When did Biodesix go public?
- Is Biodesix in the S&P 500?
- Is Biodesix in the NASDAQ 100?
- Is Biodesix in the Dow Jones?
- When was Biodesix's last earnings report?
- When does Biodesix report earnings?
- Should I buy Biodesix stock now?
What is the ticker symbol for Biodesix?
The ticker symbol for Biodesix is NASDAQ:BDSX
Does Biodesix pay dividends?
No, Biodesix does not pay dividends
What sector is Biodesix in?
Biodesix is in the Healthcare sector
What industry is Biodesix in?
Biodesix is in the Diagnostics & Research industry
What country is Biodesix based in?
Biodesix is headquartered in United States
When did Biodesix go public?
Biodesix's initial public offering (IPO) was on October 28, 2020
Is Biodesix in the S&P 500?
No, Biodesix is not included in the S&P 500 index
Is Biodesix in the NASDAQ 100?
No, Biodesix is not included in the NASDAQ 100 index
Is Biodesix in the Dow Jones?
No, Biodesix is not included in the Dow Jones index
When was Biodesix's last earnings report?
Biodesix's most recent earnings report was on Mar 3, 2025
When does Biodesix report earnings?
The next expected earnings date for Biodesix is May 8, 2025
Should I buy Biodesix stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions